Welcome to Markets Desk, here's what's moving right now.
SoftBank Group took a serious hit in Tokyo trade today, posting its worst single-day percentage decline in six months. The catalyst was a published report indicating OpenAI missed several key internal targets, a sign that competitive pressure from rival AI labs is beginning to show up in the numbers that matter.
Pivoting to pharmaceuticals, Novartis chief executive Vas Narasimhan issued a pointed warning Tuesday about U.S. drug pricing policy under President Trump, calling the situation very difficult. He put a timeline on the pain, telling investors the real-world consequences of that policy will crystallize over the next eighteen months, a horizon that should concern anyone holding pharma exposure right now.
And on the corporate earnings front out of Japan, TDK Corporation closed out its fiscal year ended March thirty-first with net profit attributable to parent shareholders climbing seventeen percent year over year, reaching one hundred ninety-five point seven billion yen. Earnings per share rose from eighty-seven point nine eight yen to one hundred two point nine seven, a solid print that reflects continued demand in the electronic components space.
That's the tape. Markets Desk, signing off the floor.
